Steven M. Pollard
Edinburgh, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Forebrain Lineage Factor DMRTA2 Is Not Required for Maintenance of H3G34-Mutant Paediatric High-Grade Gliomas.
Journal: Journal of cellular and molecular medicine
Published: June 04, 2026
Turning cancer against itself: Programmable genetic medicines for glioblastoma.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 20, 2026
Local Tumor Microenvironment Niches Correlate With Survival And Immunotherapy Response In Human Glioblastoma.
Journal: bioRxiv : the preprint server for biology
Published: May 13, 2026
Steroid-dependent metabolic rewiring reveals novel therapeutic and imaging approaches for glioblastoma.
Journal: Science advances
Published: January 23, 2026
FAK modulates glioblastoma stem cell energetics via regulation of glycolysis and glutamine oxidation.
Journal: Disease models & mechanisms
Published: August 27, 2025
CDK12/CDK13 inhibition disrupts transcriptional elongation and replication fork progression in glioblastoma.
Journal: EMBO molecular medicine
Published: August 21, 2025
Single cell proteomic analysis defines discrete neutrophil functional states in human glioblastoma.
Journal: Nature communications
Published: August 01, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.
Journal: Immunity
Published: May 30, 2025
Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma.
Journal: Pharmaceutics
Published: March 06, 2025
SOX2 phosphorylation during mitosis limits genomic damage.
Journal: Genes & development
Published: January 30, 2025
CD47 Knock-Out Using CRISPR-Cas9 RNA Lipid Nanocarriers Results in Reduced Mesenchymal Glioblastoma Growth In Vivo.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 28, 2024
Last Updated: 09/26/2026